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Abstract
Introduction: End stage renal disease (ESRD) is a 
significant social and economic burden on Africa. 
Continuous ambulatory peritoneal dialysis (CAPD) 
was introduced as a national service in the Sudan three 
years ago. An overview of the Sudan Peritoneal Dialysis 
Program is presented.
Review: As a national scheme, the Sudan PD program was 
sequentially launched in seven centers in Sudan. CAPD 
was the modality exclusively utilized. The total number 
of patients enrolled by July 2008 was 232. Patients' mean 
age was 43 years, 23.5% were children, 63% were males, 
and 19% were diabetic. 
PD was the initial dialysis modality for 54.7% of patients, 
43.5% were referred from HD, and 1.9% had a failed 
kidney transplant. The majority of patients (62.3%) 
chose PD as the preferred dialysis modality, while the 
remainder were referred from HD to PD because of 
vascular access problems or hemodynamic instability. 
One third of patients required assisted PD, and 17% 
needed urgent initiation of dialysis. 
The cumulative peritonitis rate was one episode per 10.8 
patient months. Touch contamination, urgent initiation 
of dialysis and execution of dialysis by family members 
other than trained helpers were among the identified 
predisposing factors.  
Conclusion: The establishment and operation of the 
Sudan PD program over the past three years have indicated 
that it is a promising project with multifaceted success. 
There is, however, an ongoing need for retraining of 
patients and staff. Early selection and careful preparation 
for potential PD candidates is also of vital importance to 
reduce the need for urgent dialysis initiation.
Key words: peritoneal dialysis, CAPD, renal replacement 
therapy, Sudan, Africa
Introduction
End stage renal disease (ESRD) is a substantial social 
and economic problem worldwide, and one that is 
increasing. Both incidence and prevalence of treated 
ESRD are increasing [1]. The global total cumulative cost 
for renal replacement therapy (RRT) is over one trillion 
US$. The cost and complexity of RRT make it extremely 
challenging for developing countries.
Considerable progress has been made during the past 
decade in the practice and theory of peritoneal dialysis 
(PD) for ESRD [2]. First, the widespread introduction of 
automated peritoneal dialysis (APD), whereby dialysis 
fluid is exchanged frequently while the patient is asleep, 
improves ultrafiltration and further reduces the time 
that the patient needs to devote to dialysis procedures. 
Second, the introduction of icodextrin dialysis fluid, 
containing a polyglucose that maintains a long-term 
osmotic pressure gradient, has reduced the problem 
of negative ultrafiltration during the night exchange 
or long day exchanges [3]. Third, the improvements 
in connector technology and training techniques have 
markedly reduced peritonitis frequency. The introduction 
of biocompatible peritoneal dialysis fluids has reduced 
dialysis discomfort and promises further reduction in 
peritonitis frequency and better long-term preservation 
of peritoneal function. 
Recent studies have shown an adjusted survival 
advantage for PD compared with hemodialysis (HD), 
particularly during the first 2 years of dialysis [4, 5]. 
Technique failure rates for PD at 7% to 11% per year [6] 
are generally higher than for HD, either due to patient 
"burn-out" and reduced motivation due to increasing 
morbidity, recurrent peritonitis, or peritoneal membrane 
failure. The ''integrated care'' approach to ESRD [7] 
does not consider this relatively higher failure rate to 
be a contraindication. This concept advocates that HD, 
PD, and renal transplantation should all be offered to the 
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patient in an unbiased way, and that all three modalities 
may be a part of treatment during the patient's lifetime. 
For many, PD will be a reasonable initial choice, hopefully 
followed by renal transplantation, but otherwise with 
timely conversion to HD should complications arise from 
PD. [8, 9]
PD is an efficient dialysis modality that can be tailored to 
the individual patient's clinical and social requirements. 
It permits a high degree of social rehabilitation and travel 
freedom. Given an informed choice, approximately half 
of patients will choose PD [10]. However, about 20% of 
patients will be unsuitable for PD either due to abdominal 
problems (e.g. hernias, multiple operations), physical 
disabilities (e.g. hemiparesis), or psychological problems 
(e.g. dementia, noncompliance). Thus, the overall rates 
of newly initiated PD cannot be expected to be as high. 
PD remains underutilized in many countries. Blake and 
Finkelstein speculated on the reasons for the decline in 
chronic PD utilization in the United States and Canada 
[11]. They suggested that a variety of factors contributed 
to this decline, such as the increased age of patients, the 
increased severity of illness, the increased availability 
of HD facilities, the challenges of running a PD unit 
with a limited number of patients, a lack of focus on 
the education of the patient with chronic kidney disease 
(CKD), and the inadequate training of nephrologists in 
chronic PD therapy. 
Regarding Africa, scant published data exits about the 
prevalent use of chronic PD in the continent. A recent 
survey published in the previous issue of this Journal 
provided important information about the distribution 
of RRT in different African countries [12]. It has shown 
that PD is routinely available in 12 countries (5 in North 
Africa, 7 in South Africa), and that it is only being 
delivered in the public sector. In most of these countries 
it has been introduced recently and most units offer 
acute hard catheter PD, only a few units offer continuous 
ambulatory peritoneal dialysis (CAPD). The total number 
of PD patients is around 1,800 and the prevalence is 
less than 15 pmp in all countries, while it is more than 
100 pmp in Western Europe. It is often more expensive 
than HD because all components, including fluids are 
imported.
Sudan is the largest country in Africa with a total area 
of 2,505,810 sq km, and a total population of about 36 
million. The annual population growth rate is 2.2% and 
the rural population constitutes about 60%. The Median 
age of the population is 20.4 years while the percentage 
of those 60 years of age and above is 5.8%. 
There is no national renal registry in the Sudan but 
we estimate the prevalence of CKD to be about 5.1% 
among the adult population, based on a pilot study on 
the prevalence of CKD in police forces households in 
Khartoum, Sudan (unpublished data). ESRD is projected 
to affect 5400 new cases per year, with an estimated 
incidence of 150 new cases per million of population 
per year. Center-based HD is limited and restricted to 
few major towns. Trained staff and dialysis machines 
are scarce. Although the HD treatment cost is mainly 
borne by the federal government, it is far from enough to 
address the growing numbers of ESRD patients. Kidney 
transplantation is offered in few major hospitals. The 
growing number of successful transplants is encouraging. 
However, many patients are hampered from that option 
by the prohibitive cost of preparatory investigations and 
life-long medications as well as some severely advanced 
comorbidities. Hard-catheter acute PD is widely available 
as a temporary life-saving intervention for uremic patients 
who tend to present late. 
As of December 2007, the total number of patients 
on regular hemodialysis in the Sudan was 2750. The 
registered number of HD centers in the country is 27. The 
total number of qualified nephrologists is 20. One third 
of all patients on HD live outside the capital Khartoum; 
most of them are being looked after by non-nephrologists. 
The dialysis treatment cost is borne by the Federal 
government and the cost of a single HD session is about 
100 US$. Most patients undergo twice weekly HD that is 
being delivered in 21 public and 6 private centers. This 
brings the total annual cost to 10,400 US$ per patient. The 
current annual PD cost for a single patient is 11,680 US$ 
and is all delivered at public hospitals. The total physician 
and facility reimbursement for HD is 70 US$ per session 
while none has been established for PD thus far. The 
transplantation program has recently been rejuvenated. 
The number of renal transplant operations has steadily 
increased with a total of 430 operations performed in the 
last seven years, all from living donors [13].
Organization of the Sudan PD Program
CAPD was introduced as a national service for the first 
time in Sudan in June of 2005. The Sudan PD program 
is fully funded by the Federal State and the CAPD fluids 
are provided by the Central Medical Supplies (CMS) 
Corporation. As a national experiment, the program was 
launched in five adult and two pediatric centers in Greater 
Khartoum, the capital city of the Country. By the middle 
of 2008 the first regional center outside Khartoum was 
established in Medani, the capital of the Gezira State. In 
each center there are 1-2 nephrologists or experienced 
general physicians and trained nurses (Table 1).
The Sudan PD Program has a central headquarters; it 
utilizes an integrated system for all patients with unified 
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databases, protocols, and fluid transfer arrangements. 
Monthly meetings are carried out to discuss all individual 
patient problems, update center reports and to design 
protocols for preoperative preparation, follow up, 
peritonitis and exit site infection treatments. Home visits 
are carried out and continuing staff education programs 
are regularly provided. In subsequent years, the program 
will accommodate more centers after careful selection. 
The most important criteria for center inclusion are “an 
enthusiastic nephrologist interested in PD and willing 
to work in a team fashion” and a “willing hospital 
administration”. Arrangements to meet other cost items 
are still being discussed with CMS.
The “integrated multi-center” approach is probably the 
most important aspect of the program organization. The 
program came to being thanks to the National Ribat 
University (NRU) which accepted the program as a 
research project by the Principal Investigator (HA). NRU 
supported the infrastructure needed to accommodate the 
“Leading Center” in the university premises. The CMS 
Corporation, which is a Federal State organization dealing 
with medical supplies to the whole Country, agreed to 
“give the proposed integrated multi-center program a try” 
as a free medical service to some ESRD patients selected 
by the organizers of the program. Credit must also be 
given to all the team members of the seven centers, who 
fully cooperated and enthusiastically accepted the unified 
protocols and regularly attended the monthly meetings 
which are held alternately in participating centers. 
Patients' characteristics 
Between June 2005 and July 2008, 232 patients joined 
the Sudan PD program. Patients' mean age was 43 years, 
with a range of 9 months to 81 years, 23.5% of all patients 
belonged to the pediatric age group, 63% of patients were 
males, and 19% were diabetic.
A little over half of the patients resided outside Khartoum. 
Some of them come from as far as Port Sudan, about 
a thousand kilometer North East of Khartoum, and 
Nyala, close to the Western border of the country, about 
a thousand kilometer West of Khartoum. CAPD was 
considered the only option for a lot of them because of 
unavailability of HD facilities in those regions of the 
country (Figure 1). 
PD was the initial dialysis modality for 54.7% of 
patients, 43.5% were referred from HD, and 1.9% had a 
failed kidney transplant. The majority of patients chose 
PD (62.3%) as their preferred dialysis modality, while 
8% of patients were referred to PD because they were 
not medically suitable for HD, and 29.7% were referred 
to PD because of vascular access problems. Almost one 
third of patients required assisted PD, and about 17% of 
patients required urgent initiation of dialysis.
Peritonitis Rates
The cumulative peritonitis rate at the end of the first 
year was one episode per 21.5 patient month or 0.55 
episodes per year. This was well within the acceptable 
range recommended by the ISPD guidelines; one episode 
per 18 patient-months or 0.67 episode per year at risk 
[14], though some individual center did not quite attain 
the targeted range. By July of 2008, however, the overall 
rate had dropped to one episode per 10.8 patient months. 
This deterioration in efficacy was probably due to staff 
instability, as nurses were not always fully assigned 
to the program and many of them were transferred by 
prospective hospital administrations to other departments 
at times of seeming crisis. This shortcoming has largely 
Table 1: Distribution of PD patients between different PD centers by the end of July 2008 
Center Total patients enrolled
Frequency Percentage (%)
Ribat University Hospital 101 43.5
Military Hospital 40 17.2
Soba Pediatric Center 40 17.2
Khartoum Teaching Hospital 19 8.2
Jaafar Ibn Children's Hospital 14 6
Ibn Sina Specialized Hospital 10 4.3
Medani Center for Kidney Disease and Surgery 8 3.4
Total 232 100
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been overcome now and the latest (November 2008) 
peritonitis rates were recorded as one episode per 11.3 
patient months. We hope this trend towards improvement 
will continue over the coming months.
Touch contamination was incriminated in a considerable 
proportion of peritonitis episodes. Touch contamination 
was defined as a break in the sterile technique by 
which dialysis is supposed to be performed. Examples 
encountered were failure to wash or dry hands 
appropriately before performing the procedure and 
inattention to avoid the connector tips contamination when 
connecting and disconnecting the transfer set and the twin 
bag. Problems seen with children included execution of 
dialysis by family members other than trained helpers 
and, in general, less meticulous hygienic adherence. For 
logistical reasons, young children are trained to utilize 
appropriate portions of the same 2-liter adult bags for 
CAPD and discard the remainder. A concern is that some 
parents might be re-using the bags for “finding it difficult 
to throw those precious bags away.”  Urgent dialysis was 
also recognized as an important predictor of peritonitis. 
The culture-negative peritonitis rate was 53%; higher 
than the maximum of 20% allowed by the ISPD 
recommendations [14]. There are several difficulties 
which impede implementing the appropriate processing 
technique of dialysate samples on patient suspected of 
having peritonitis as advised by the ISPD guidelines in 
our setting. Large volume centrifuging devises are not 
available. Blood culture bottles are expensive and not 
uniformly available. The culture procedure done in most 
of our laboratories is injecting a few milliliters of the 
dialysate directly into solid culture media and checking 
daily for growth. Storage of the rest of whole bags in 
an incubator is performed in some centers in order to 
encourage growth while re-testing the fluid daily.
The cumulative peritonitis rate stresses the ongoing need 
for retraining of the patients and the program staff. Since 
the system is an integrated system, the difficulties met 
by each center are discussed in detail and team-members 
give advice freely. Therefore, it is very likely that mistakes 
will be corrected and records improved. The appreciation 
–incentive system has also proven very effective: the 
“Best Center” in patient care, “Least Peritonitis,” “Best 
Research Paper” etc, are looked upon as achievements 
that are worth competing for. 
Proper hand hygiene techniques need to be well-taught 
and persistently respected by patients and medical staff. 
Early selection and careful preparation for potential PD 
candidates is also of vital importance to obviate the need 
for urgent dialysis initiation.
Conclusion
The Sudan Peritoneal Dialysis Program is now a reality 
and is promising to serve a large sector of ESRD patients 
in the Sudan. The total cost of therapy is looked upon as 
cost-effective as it excludes hospital admission charges 
and working days loss. The treatment is provided free 
of charge. However, a major current problem is the cost 
of laboratory investigations and medications. Ways and 
means are being sorted out to help patients with these in 
order to improve the performance of the procedure and 
assure its continued success.  
Challenges also include maintaining a satisfactorily low 
infection rate which does require continuous training and 
retraining as well as meticulousness in part of the patient 
and providers. Overall, PD is an important addition to 
RRT armamentarium in the Sudan. It probably should 
be considered as the treatment of first choice for most 
ESRD patients as advocated in the integrated dialysis 
care strategy.
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